MIKA MEDICAL Launches Comfort-M, a New Continuous Needleless Injection System in Korea

MIKA MEDICAL (CEO Lee Ji-eun) succeeded in developing Comfort-M, a new continuous needleless injection system in Korea.

Founded in 1990, MIKA MEDICAL developed Korea’s first patented needleless injection (Comfort-In) technology, used for diabetes, local anesthesia, and hormone injections. Comfort-In helped to reduce the pain of diabetics by eliminating skin damage caused by periodic needle injection.

With the vision to apply needleless syringes to a wider field based on this technology, the company invented an advanced type of medical device in Korea, Comfort-M, a new continuous needleless injection system.

After extensive research, the company invented a needleless injection system capable of injecting 3cc of drugs 30 times continuously at 0.1cc increments – an innovative injection technology in Korea that can be widely used not only for skin beauty, but also for various medical and pharmaceutical applications.

This product has no visible needles. When the drug is injected into the body, it is immediately dispersed under the skin, so the effect can be fast with very short treatment time. The drug is injected at constant pressure, making it easy to use. The risk of infection is also eliminated by making all parts that contact the skin and the drug consumable. No Infection Injection.

Contact Information

Elin Kim

PR Manager

Onplus

Contact via E-mail